FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036537407> ?p ?o ?g. }

• W3036537407 endingPage "1134" @default.
• W3036537407 startingPage "1127" @default.
• W3036537407 abstract "We aimed to describe the impact of time to response on the outcomes of 75 patients with accelerated-phase chronic myeloid leukemia (CML-AP) at diagnosis. Patients had at least 1 feature of AP: blasts ≥15% (n = 2), basophils ≥20% (n = 19), platelets <100 × 109 /L (n = 7), cytogenetic clonal evolution (n = 34), or more than one factor (n = 13). Thirty-three patients received imatinib; 42 received a second-generation tyrosine kinase inhibitor (2GTKI) (19 dasatinib and 23 nilotinib). We used chi-square and Kaplan-Meier analyses to determine the impact of various degrees of molecular and cytogenetic response at early time points (3 and 6 months) on rates of overall cytogenetic and molecular response, overall survival (OS), event-free survival (EFS), transformation-free survival (TFS), and failure-free survival (FFS). After a median follow-up of 96 months (range: 18-224 months), the overall rate of complete cytogenetic response was 79%, of major molecular response, 71%, and of molecular reponse (MR)4.5, 59%. Patients who achieved a major cytogenetic response (MCyR) (n = 49) at 3 months had significantly better 3-year OS (94% vs 75%; P = .002), TFS (98% vs 73%; P < .001), EFS (93% vs 42%; P < .001), and FFS (83% vs 25%; P < .001) rates than patients who did not have MCyR at 3 months. Most (67%) who eventually achieved sustained MR4.5 had achieved MCyR at 3 months. In de novo CML-AP, early response at 3 and 6 months is a strong determinant of long-term outcome." @default.
• W3036537407 created "2020-06-25" @default.
• W3036537407 creator A5000750846 @default.
• W3036537407 creator A5009316700 @default.
• W3036537407 creator A5009582343 @default.
• W3036537407 creator A5015140142 @default.
• W3036537407 creator A5019456066 @default.
• W3036537407 creator A5020340537 @default.
• W3036537407 creator A5027124893 @default.
• W3036537407 creator A5027994801 @default.
• W3036537407 creator A5028845635 @default.
• W3036537407 creator A5030500582 @default.
• W3036537407 creator A5048913229 @default.
• W3036537407 creator A5049385583 @default.
• W3036537407 creator A5055045706 @default.
• W3036537407 creator A5059138314 @default.
• W3036537407 creator A5059747862 @default.
• W3036537407 creator A5061026876 @default.
• W3036537407 creator A5085521139 @default.
• W3036537407 creator A5090435894 @default.
• W3036537407 date "2020-07-23" @default.
• W3036537407 modified "2023-10-15" @default.
• W3036537407 title "The clinical impact of time to response in de novo accelerated‐phase chronic myeloid leukemia" @default.
• W3036537407 cites W1965303921 @default.
• W3036537407 cites W1999749854 @default.
• W3036537407 cites W2021413430 @default.
• W3036537407 cites W2034469570 @default.
• W3036537407 cites W2038120084 @default.
• W3036537407 cites W2039978091 @default.
• W3036537407 cites W2085342571 @default.
• W3036537407 cites W2092509861 @default.
• W3036537407 cites W2148743957 @default.
• W3036537407 cites W2329659524 @default.
• W3036537407 cites W2884705408 @default.
• W3036537407 cites W3009751715 @default.
• W3036537407 doi "https://doi.org/10.1002/ajh.25907" @default.
• W3036537407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32557828" @default.
• W3036537407 hasPublicationYear "2020" @default.
• W3036537407 type Work @default.
• W3036537407 sameAs 3036537407 @default.
• W3036537407 citedByCount "8" @default.
• W3036537407 countsByYear W30365374072021 @default.
• W3036537407 countsByYear W30365374072022 @default.
• W3036537407 countsByYear W30365374072023 @default.
• W3036537407 crossrefType "journal-article" @default.
• W3036537407 hasAuthorship W3036537407A5000750846 @default.
• W3036537407 hasAuthorship W3036537407A5009316700 @default.
• W3036537407 hasAuthorship W3036537407A5009582343 @default.
• W3036537407 hasAuthorship W3036537407A5015140142 @default.
• W3036537407 hasAuthorship W3036537407A5019456066 @default.
• W3036537407 hasAuthorship W3036537407A5020340537 @default.
• W3036537407 hasAuthorship W3036537407A5027124893 @default.
• W3036537407 hasAuthorship W3036537407A5027994801 @default.
• W3036537407 hasAuthorship W3036537407A5028845635 @default.
• W3036537407 hasAuthorship W3036537407A5030500582 @default.
• W3036537407 hasAuthorship W3036537407A5048913229 @default.
• W3036537407 hasAuthorship W3036537407A5049385583 @default.
• W3036537407 hasAuthorship W3036537407A5055045706 @default.
• W3036537407 hasAuthorship W3036537407A5059138314 @default.
• W3036537407 hasAuthorship W3036537407A5059747862 @default.
• W3036537407 hasAuthorship W3036537407A5061026876 @default.
• W3036537407 hasAuthorship W3036537407A5085521139 @default.
• W3036537407 hasAuthorship W3036537407A5090435894 @default.
• W3036537407 hasBestOaLocation W30365374071 @default.
• W3036537407 hasConcept C121608353 @default.
• W3036537407 hasConcept C126322002 @default.
• W3036537407 hasConcept C143998085 @default.
• W3036537407 hasConcept C203014093 @default.
• W3036537407 hasConcept C2777413986 @default.
• W3036537407 hasConcept C2777583451 @default.
• W3036537407 hasConcept C2778729363 @default.
• W3036537407 hasConcept C2778820342 @default.
• W3036537407 hasConcept C2779536868 @default.
• W3036537407 hasConcept C3019892230 @default.
• W3036537407 hasConcept C71924100 @default.
• W3036537407 hasConcept C90924648 @default.
• W3036537407 hasConceptScore W3036537407C121608353 @default.
• W3036537407 hasConceptScore W3036537407C126322002 @default.
• W3036537407 hasConceptScore W3036537407C143998085 @default.
• W3036537407 hasConceptScore W3036537407C203014093 @default.
• W3036537407 hasConceptScore W3036537407C2777413986 @default.
• W3036537407 hasConceptScore W3036537407C2777583451 @default.
• W3036537407 hasConceptScore W3036537407C2778729363 @default.
• W3036537407 hasConceptScore W3036537407C2778820342 @default.
• W3036537407 hasConceptScore W3036537407C2779536868 @default.
• W3036537407 hasConceptScore W3036537407C3019892230 @default.
• W3036537407 hasConceptScore W3036537407C71924100 @default.
• W3036537407 hasConceptScore W3036537407C90924648 @default.
• W3036537407 hasIssue "10" @default.
• W3036537407 hasLocation W30365374071 @default.
• W3036537407 hasLocation W30365374072 @default.
• W3036537407 hasOpenAccess W3036537407 @default.
• W3036537407 hasPrimaryLocation W30365374071 @default.
• W3036537407 hasRelatedWork W1963599260 @default.
• W3036537407 hasRelatedWork W1973550048 @default.
• W3036537407 hasRelatedWork W2025422981 @default.
• W3036537407 hasRelatedWork W2056917031 @default.
• W3036537407 hasRelatedWork W2070410089 @default.

• next